Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial is a research paper published in UNC Libraries (2024). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 1R01CA276684-01
Modulating the PD-1/PD-L1 checkpoint to promote antitumor activity of HER2 CAR T cells in patients with sarcoma
National Institutes of Health
Grant: 3P30CA125123-09S3
Baylor College of Medicine Cancer Center
National Institutes of Health
Grant: 1U54CA232568-01
Discovery and Development of Optimal Immunotherapeutic Strategies for Childhood Cancers
National Institutes of Health
Grant: 4K12CA090433-15
Pediatric Oncology Clinical Research Training Program
National Institutes of Health
Grant: 5R50CA243707-05
Single Cell Spatial Analysis in Tissue
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
National Institutes of Health
Grant: 2T32HL092332-16
Training In Cell and Gene Therapy
National Institutes of Health
Grant: 3P30CA047904-07S1
CANCER CENTER SUPPORT GRANT
FWCI
0.18
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals